AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 97 filers reported holding AIMMUNE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,120,000 | -18.6% | 61,571 | -60.5% | 0.00% | 0.0% |
| Q2 2020 | $2,605,000 | +14.8% | 155,924 | -0.9% | 0.00% | 0.0% |
| Q1 2020 | $2,269,000 | -58.7% | 157,302 | -4.3% | 0.00% | -50.0% |
| Q4 2019 | $5,500,000 | +54.9% | 164,333 | -3.1% | 0.00% | +100.0% |
| Q3 2019 | $3,550,000 | +31.4% | 169,556 | +30.7% | 0.00% | 0.0% |
| Q2 2019 | $2,702,000 | +2.7% | 129,778 | +10.3% | 0.00% | 0.0% |
| Q1 2019 | $2,631,000 | +25.3% | 117,679 | +34.2% | 0.00% | 0.0% |
| Q4 2018 | $2,099,000 | -1.0% | 87,716 | +12.8% | 0.00% | 0.0% |
| Q3 2018 | $2,121,000 | +341.9% | 77,777 | +335.1% | 0.00% | – |
| Q2 2018 | $480,000 | -13.5% | 17,876 | +2.4% | 0.00% | – |
| Q1 2018 | $555,000 | +3600.0% | 17,463 | +4412.4% | 0.00% | – |
| Q4 2017 | $15,000 | -81.5% | 387 | -88.2% | 0.00% | – |
| Q3 2017 | $81,000 | +8000.0% | 3,269 | +4038.0% | 0.00% | – |
| Q2 2017 | $1,000 | -94.7% | 79 | -90.4% | 0.00% | – |
| Q1 2017 | $19,000 | -57.8% | 826 | -62.4% | 0.00% | – |
| Q4 2016 | $45,000 | +4400.0% | 2,199 | +2581.7% | 0.00% | – |
| Q3 2016 | $1,000 | – | 82 | +310.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 20 | -95.0% | 0.00% | – |
| Q3 2015 | $10,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |